Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Abstract The objective of this study was to investigate the clinical significance and roles of tumor progression locus 2 (TPL2) and peptidyl-prolyl cis–trans isomerase 1 (Pin1) in the occurrence and development of breast invasive ductal carcinoma (IDC). Immunohistochemistry was used to detect the ex...
Auteurs principaux: | Qin Yu, Dan Wan, Rong Fu, Feng Li, Yutao Zhang |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Nature Portfolio
2023-10-01
|
Collection: | Scientific Reports |
Accès en ligne: | https://doi.org/10.1038/s41598-023-44660-z |
Documents similaires
-
Schirrous invasive ductal carcinoma of the breast overexpress p53 oncoprotein
par: Flávia Silva Ferrini, et autres
Publié: (2001-01-01) -
The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis
par: Yun Wu, et autres
Publié: (2017-12-01) -
UPAR Overexpression Could Be a Potential Favorable Prognostic Marker in Invasive Ductal Carcinoma of Breast
par: Ata Abbasi, et autres
Publié: (2022-06-01) -
DCIS (Ductal carcinoma in situ)-like invasive ductal carcinoma of the breast
par: Huanyu Zhao, et autres
Publié: (2022-10-01) -
Different distribution of breast ductal carcinoma <it>in situ</it>, ductal carcinoma <it>in situ</it> with microinvasion, and invasion breast cancer
par: Wei Zhang, et autres
Publié: (2012-12-01)